400 related articles for article (PubMed ID: 36543743)
1. Research progress of exosomes as drug carriers in cancer and inflammation.
Feng Q; Zhang Y; Fang Y; Kong X; He Z; Ji J; Yang X; Zhai G
J Drug Target; 2023 Apr; 31(4):335-353. PubMed ID: 36543743
[TBL] [Abstract][Full Text] [Related]
2. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
3. Exosomes as Targeted Delivery Drug System: Advances in Exosome Loading, Surface Functionalization and Potential for Clinical Application.
Guo ZY; Tang Y; Cheng YC
Curr Drug Deliv; 2024; 21(4):473-487. PubMed ID: 35702803
[TBL] [Abstract][Full Text] [Related]
4. Current Strategies for Exosome Cargo Loading and Targeting Delivery.
Zeng H; Guo S; Ren X; Wu Z; Liu S; Yao X
Cells; 2023 May; 12(10):. PubMed ID: 37408250
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
Ramesh D; Bakkannavar S; Bhat VR; Sharan K
F1000Res; 2023; 12():329. PubMed ID: 37868300
[TBL] [Abstract][Full Text] [Related]
6. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
7. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
8. Application of exosome engineering modification in targeted delivery of therapeutic drugs.
Wang Y; Jiang M; Zheng X; He Y; Ma X; Li J; Pu K
Biochem Pharmacol; 2023 Sep; 215():115691. PubMed ID: 37481135
[TBL] [Abstract][Full Text] [Related]
9. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
Srivastava A; Rathore S; Munshi A; Ramesh R
Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
[TBL] [Abstract][Full Text] [Related]
10. Engineering exosomes as refined biological nanoplatforms for drug delivery.
Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges.
Oshchepkova A; Zenkova M; Vlassov V
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108446
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles in the Development of Cancer Therapeutics.
Sun H; Burrola S; Wu J; Ding WQ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
[TBL] [Abstract][Full Text] [Related]
14. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
15. Design strategies and application progress of therapeutic exosomes.
Liu C; Su C
Theranostics; 2019; 9(4):1015-1028. PubMed ID: 30867813
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
17. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers.
Moloudizargari M; Asghari MH; Goel A
Biochem Pharmacol; 2021 Oct; 192():114714. PubMed ID: 34332957
[TBL] [Abstract][Full Text] [Related]
19. Exosomes as drug delivery systems: A brief overview and progress update.
Patil SM; Sawant SS; Kunda NK
Eur J Pharm Biopharm; 2020 Sep; 154():259-269. PubMed ID: 32717385
[TBL] [Abstract][Full Text] [Related]
20. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
